Purchase Order 75N98026P01473
- Not listed
- This federal contract award was issued by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency, to the University of Maryland Medical System Corporation (UMMSC), a non-profit hospital organization based in Baltimore, MD. The $24,999.99 firm fixed-price purchase order is to provide a procedure at an outside hospital center for a patient on an NHLBI clinical research protocol, in order to maintain patient safety and continuity of care. The contract does not have a set-aside...
- <p>The National Heart Lung and Blood Institute awarded a firm fixed price purchase order to University of Maryland, Baltimore for multi-scale phenotyping of heart failure with a ceiling value of $702,063.57 and an award date of June 16, 2025. Work is performed in Baltimore, Maryland, with an ultimate completion date of September 15, 2030. The purchase order calls for advanced biomedical research services supporting the Institute's cardiovascular research mission.</p>
- The National Heart Lung and Blood Institute awarded a purchase order to Medstar Health Research Institute Inc. for $23,925.00 on November 10, 2020, to process samples for NIH/Medstar Health Baltimore cell-free DNA COVID-19 research over an estimated one-year period. Performance occurs at University Park, Maryland. The order funds laboratory sample processing services in support of pulmonary function research conducted by Sean Agbor-Enoh and NHLBI pulmonary function lab staff, under firm...
- <p>The National Heart Lung and Blood Institute awarded a purchase order to University of Maryland, Baltimore for $13,126.84 on March 24, 2017, to provide scientific support services to the NHLBI Division of Intramural Research. Work is performed in Bethesda, Maryland for a one-year period of performance ending September 7, 2017. The contract carries firm fixed-price pricing and no set-aside designation.</p>
- <p>The National Heart, Lung, and Blood Institute awarded a purchase order to University of Maryland Medical System Corporation valued at $249,999 on July 15, 2020, for division of intramural research medical support services. Performance is located in Bethesda, Maryland. The contract is firm fixed price with an ultimate completion date of August 31, 2020. No set-aside category applies.</p>
- <p>The National Heart Lung and Blood Institute issued a purchase order to the State of Maryland valued at $60,197.00 on March 28, 2018 for heart and lung transplant sample collection services. Performance occurs in Baltimore, Maryland. The order is firm fixed price with an ultimate completion date of March 31, 2022. No set-aside applies.</p>
- This is a $121,776 firm fixed-price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the U.S. Department of Health and Human Services, to the University of Maryland Medical System Corporation (UMMSC), a non-profit hospital and medical system. The contract is for lymphocyte collection services, which are likely supporting medical research protocols or clinical trials overseen by the NHLBI. UMMSC has a history of providing specialized...
- <p>The National Heart Lung and Blood Institute awarded a purchase order to Reprocell U.S.A., Inc. for DNA and RNA extraction from whole blood with a ceiling value of $73,338.90, effective April 15, 2020, and completing April 14, 2021. Work is performed at Calverton, Maryland. The order is firm fixed price with no small business set-aside.</p>
- <p>The National Heart Lung and Blood Institute awarded a purchase order to Cerba Research USA, Inc. valued at $112,198 on July 31, 2018, to procure serum biomarker assay services. Work is performed in Bethesda, Maryland. The order is firm fixed price with an ultimate completion date of July 30, 2019. No small business set-aside applied to this procurement.</p>
- The National Heart Lung and Blood Institute awarded a purchase order to University of Maryland, Baltimore to provide support services for the NHLBI Pulmonary Critical Care Fellowship Program, with a ceiling value of $595,206, awarded on June 29, 2015. The order carries a firm fixed-price structure with no set-aside designation. Performance occurs in Bethesda, Maryland. The period of performance runs one year from the award date, with potential for two additional option years. The contract...
The National Heart, Lung and Blood Institute awarded a purchase order to University of Maryland, Baltimore for off-hours specimen processing services, valued at $25,000.00, with an award date of September 30, 2026. Work is performed in Baltimore, Maryland. The order covers centrifugation of peripheral blood samples, red blood cell depletion of peripheral blood mononuclear cells, cell counting, and cryopreservation of samples from patients with acute respiratory distress syndrome or respiratory failure on venovenous extracorporeal membrane oxygenation. Processing occurs off-hours—Monday through Friday 5 PM to 5 AM, weekends, and holidays—under direction of Dr. Robert Christenson in the Laboratory of Pathology to preserve sample integrity for downstream gene and protein analysis. The performance period runs from September 30, 2026 through April 30, 2027. The procurement was conducted under FAR Part 13 Simplified Acquisition Procedures as a sole-source award justified by the 2024 Bench-to-Bedside Award program designation, which identified University of Maryland Medical Center as the sole clinical collaborator to maintain research plan integrity and protect patient confidentiality.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Off Hours Specimen Processing Service | 75N98026Q01087 | Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute | Pre-Solicitation 1/1 | 8/31/26, 12:48 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.0k | 9/18/26 |